Radiochemotherapy for Bladder Cancer

World Health Organization, 2008 Eble, 2004 el-Mawla, 2001, Bladder cancer in Africa: update, Semin Oncol, 28, 174, 10.1053/sonc.2001.21961 Groeneveld, 1996, Bladder cancer in various population groups in the greater Durban area of KwaZulu-Natal, South Africa, Br J Urol, 78, 205, 10.1046/j.1464-410X.1996.09310.x Ochicha, 2003, Bladder cancer in Kano—a histopathological review, West Afr J Med, 22, 202 Sow, 2006, Prog Urol, 16, 36 Brennan, 2000, Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies, Int J Cancer, 86, 289, 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M Brennan, 2001, The contribution of cigarette smoking to bladder cancer in women (pooled European data), Cancer Causes Control, 12, 411, 10.1023/A:1011214222810 Siemiatycki, 2004, Listing occupational carcinogens, Environ Health Perspect, 112, 1447, 10.1289/ehp.7047 International Agency for Research on Cancer, 2008 Volkmer, 2005, Cyclophosphamide is contraindicated in patients with a history of transitional cell carcinoma, Clin Rheumatol, 24, 319, 10.1007/s10067-004-1032-2 Bedwani, 1998, Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt, Br J Cancer, 77, 1186, 10.1038/bjc.1998.197 Parkin, 2006, The global health burden of infection-associated cancers in the year 2002, Int J Cancer, 118, 3030, 10.1002/ijc.21731 Pelucchi, 2006, Mechanisms of disease: the epidemiology of bladder cancer, Nat Clin Pract Urol, 3, 327, 10.1038/ncpuro0510 Commission on Cancer/American Cancer Society Kiemeney, 1994, Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975–1989, Eur J Cancer, 30A, 1134, 10.1016/0959-8049(94)90472-3 Roazzi, 2003, Electronic availability of EUROCARE-3 data: a tool for further analysis, Ann Oncol, 14, v150, 10.1093/annonc/mdg757 Babjuk Rodel, 2002, Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results, J Clin Oncol, 20, 3061, 10.1200/JCO.2002.11.027 Gospodarowicz, 1989, Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis, J Urol, 142, 1448, 10.1016/S0022-5347(17)39122-X Weiss, 2008, Radiochemotherapeutic options for bladder cancer, Aktuelle Urol, 39, 123, 10.1055/s-2008-1038150 Weiss, 2006, Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?, J Clin Oncol, 24, 2318, 10.1200/JCO.2006.05.8149 Greven, 1990, Prognostic factors in patients with bladder carcinoma treated with definitive irradiation, Cancer, 65, 908, 10.1002/1097-0142(19900215)65:4<908::AID-CNCR2820650415>3.0.CO;2-Z Moonen, 1998, Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control, Int J Radiat Oncol Biol Phys, 42, 525, 10.1016/S0360-3016(98)00263-6 Quilty, 1986, Prognostic indices for bladder cancer: an analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy, Radiother Oncol, 7, 311, 10.1016/S0167-8140(86)80060-3 Smaaland, 1991, Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients, Br J Urol, 67, 61, 10.1111/j.1464-410X.1991.tb15071.x Pollack, 1994, Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors, Int J Radiat Oncol Biol Phys, 30, 267, 10.1016/0360-3016(94)90004-3 Shipley, 1985, Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival, J Urol, 134, 679, 10.1016/S0022-5347(17)47381-2 Pos, 2006, Radical radiotherapy for invasive bladder cancer: what dose and fractionation schedule to choose?, Int J Radiat Oncol Biol Phys, 64, 1168, 10.1016/j.ijrobp.2005.09.023 Naslund, 1994, Hyperfractionated radiotherapy of bladder cancer. A ten-year follow-up of a randomized clinical trial, Acta Oncol, 33, 397, 10.3109/02841869409098435 Goldobenko, 1991, Med Radiol (Mosk), 36, 14 Stuschke, 1997, Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials, Int J Radiat Oncol Biol Phys, 37, 259, 10.1016/S0360-3016(96)00511-1 Maciejewski, 1991, Dose fractionation and tumour repopulation in radiotherapy for bladder cancer, Radiother Oncol, 21, 163, 10.1016/0167-8140(91)90033-D Horwich, 2005, A randomised trial of accelerated radiotherapy for localised invasive bladder cancer, Radiother Oncol, 75, 34, 10.1016/j.radonc.2004.11.003 Kob, 1985, Strahlentherapie, 161, 673 Hata, 2006, Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy, Int J Radiat Oncol Biol Phys, 64, 1371, 10.1016/j.ijrobp.2005.10.023 Henry, 2006, X-ray volume imaging in bladder radiotherapy verification, Int J Radiat Oncol Biol Phys, 64, 1174, 10.1016/j.ijrobp.2005.09.044 Pos, 2005, Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?, Int J Radiat Oncol Biol Phys, 61, 678, 10.1016/j.ijrobp.2004.06.249 Pos, 2006, Adaptive radiotherapy for invasive bladder cancer: a feasibility study, Int J Radiat Oncol Biol Phys, 64, 862, 10.1016/j.ijrobp.2005.07.976 De Neve, 1995, Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time, Radiother Oncol, 36, 183, 10.1016/0167-8140(95)01586-6 Jenkins, 1988, Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer, Br J Urol, 62, 343, 10.1111/j.1464-410X.1988.tb04362.x Mameghan, 1995, Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder, Int J Radiat Oncol Biol Phys, 31, 247, 10.1016/0360-3016(94)E0135-7 Rodel, 2006, Trimodality treatment and selective organ preservation for bladder cancer, J Clin Oncol, 24, 5536, 10.1200/JCO.2006.07.6729 Coppin, 1996, Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group, J Clin Oncol, 14, 2901, 10.1200/JCO.1996.14.11.2901 Weiss, 2007, Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer, Int J Radiat Oncol Biol Phys, Jul 15; 68, 1072, 10.1016/j.ijrobp.2007.01.054 Dunst, 1999, Preliminary results of simultaneous radiochemotherapy with paclitaxel for urinary bladder cancer, Strahlenther Onkol, 175, 7, 10.1007/BF03215920 Kaufman, 2009, Phase I–II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy, Urology, Apr;73, 833, 10.1016/j.urology.2008.09.036 Muller, 2007, Organ-sparing treatment of advanced bladder cancer: paclitaxel as a radiosensitizer, Strahlenther Onkol, 183, 177, 10.1007/s00066-007-1651-z Nichols, 2000, Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder: a well-tolerated combination, Int J Cancer, 90, 281, 10.1002/1097-0215(20001020)90:5<281::AID-IJC5>3.0.CO;2-U Patel, 2005, A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer, Int J Radiat Oncol Biol Phys, 62, 1332, 10.1016/j.ijrobp.2005.01.004 Oh, 2009, Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trial, Int J Radiat Oncol Biol Phys, Jun 1;74, 511, 10.1016/j.ijrobp.2008.08.021 Sangar, 2005, Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer, Int J Radiat Oncol Biol Phys, 61, 420, 10.1016/j.ijrobp.2004.05.074 Caffo, 2003, Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer, Int J Radiat Oncol Biol Phys, 57, 1310, 10.1016/S0360-3016(03)00763-6 van der Zee, 2002, Heating the patient: a promising approach?, Ann Oncol, 13, 1173, 10.1093/annonc/mdf280 Wust, 2002, Hyperthermia in combined treatment of cancer, Lancet Oncol, 3, 487, 10.1016/S1470-2045(02)00818-5 Horsman, 2007, Hyperthermia: a potent enhancer of radiotherapy, Clin Oncol (R Coll Radiol), 19, 418, 10.1016/j.clon.2007.03.015 Moyer, 2008, The role of hyperthermia in optimizing tumor response to regional therapy, Int J Hyperthermia, 24, 251, 10.1080/02656730701772480 Colombo, 2003, Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma, J Clin Oncol, 21, 4270, 10.1200/JCO.2003.01.089 van der Zee, 2000, Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group, Lancet, 355, 1119, 10.1016/S0140-6736(00)02059-6 Dunst, 1994, Organ-sparing treatment of advanced bladder cancer: a 10-year experience, Int J Radiat Oncol Biol Phys, 30, 261, 10.1016/0360-3016(94)90003-5 Sauer, 1998, Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer, Int J Radiat Oncol Biol Phys, 40, 121, 10.1016/S0360-3016(97)00579-8 International Agency for Research on Cancer, 2002, vol. VIII Lin, 2009, Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer, Int J Radiat Oncol Biol Phys, 10.1016/j.ijrobp.2008.11.030 Stein, 2001, Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients, J Clin Oncol, 19, 666, 10.1200/JCO.2001.19.3.666 Dalbagni, 2001, Cystectomy for bladder cancer: a contemporary series, J Urol, 165, 1111, 10.1016/S0022-5347(05)66440-3 Madersbacher, 2003, Radical cystectomy for bladder cancer today—a homogeneous series without neoadjuvant therapy, J Clin Oncol, 21, 690, 10.1200/JCO.2003.05.101 Hautmann, 2006, Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era, J Urol, 176, 486, 10.1016/j.juro.2006.03.038 Shariat, 2006, Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium, J Urol, 176, 2414, 10.1016/j.juro.2006.08.004